TY - JOUR
T1 - Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community
AU - Singh, Prince
AU - Enders, Felicity T.
AU - Vaughan, Lisa E.
AU - Bergstralh, Eric J.
AU - Knoedler, John J.
AU - Krambeck, Amy E.
AU - Lieske, John C.
AU - Rule, Andrew D.
N1 - Funding Information:
Grant Support: This project was supported by grants DK100227 and DK83007 from the National Institute of Diabetes and Digestive and Kidney Diseases (Mayo Clinic O'Brien Urology Research Center) and made possible by the Rochester Epidemiology Project (grant number R01-AG034676; Principal Investigator: Walter A. Rocca, MD, MPH, and Barbara P. Yawn, MD, MSc). The funding source had no role in the study design, conduct, or reporting.
Publisher Copyright:
© 2015 Mayo Foundation for Medical Education and Research
PY - 2015/10
Y1 - 2015/10
N2 - Objective To determine the variation in kidney stone composition and its association with risk factors and recurrence among first-time stone formers in the general population. Patients and Methods Medical records were manually reviewed and validated for symptomatic kidney stone episodes among Olmsted County, Minnesota, residents from January 1, 1984, through December 31, 2012. Clinical and laboratory characteristics and the risk of symptomatic recurrence were compared between stone compositions. Results There were 2961 validated first-time symptomatic kidney stone formers. Stone composition analysis was obtained in 1508 (51%) at the first episode. Stone formers were divided into the following mutually exclusive groups: any brushite (0.9%), any struvite (0.9%), any uric acid (4.8%), and majority calcium oxalate (76%) or majority hydroxyapatite (18%). Stone composition varied with clinical characteristics. A multivariable model had a 69% probability of correctly estimating stone composition but assuming calcium oxalate monohydrate stone was correct 65% of the time. Symptomatic recurrence at 10 years was approximately 50% for brushite, struvite, and uric acid but approximately 30% for calcium oxalate and hydroxyapatite stones (P<.001). Recurrence was similar across different proportions of calcium oxalate and hydroxyapatite (P for trend=.10). However, among calcium oxalate stones, 10-year recurrence rate ranged from 38% for 100% calcium oxalate dihydrate to 26% for 100% calcium oxalate monohydrate (P for trend=.007). Conclusion Calcium stones are more common (93.5% of stone formers) than has been previously reported. Although clinical and laboratory factors associate with the stone composition, they are of limited utility for estimating stone composition. Rarer stone compositions are more likely to recur.
AB - Objective To determine the variation in kidney stone composition and its association with risk factors and recurrence among first-time stone formers in the general population. Patients and Methods Medical records were manually reviewed and validated for symptomatic kidney stone episodes among Olmsted County, Minnesota, residents from January 1, 1984, through December 31, 2012. Clinical and laboratory characteristics and the risk of symptomatic recurrence were compared between stone compositions. Results There were 2961 validated first-time symptomatic kidney stone formers. Stone composition analysis was obtained in 1508 (51%) at the first episode. Stone formers were divided into the following mutually exclusive groups: any brushite (0.9%), any struvite (0.9%), any uric acid (4.8%), and majority calcium oxalate (76%) or majority hydroxyapatite (18%). Stone composition varied with clinical characteristics. A multivariable model had a 69% probability of correctly estimating stone composition but assuming calcium oxalate monohydrate stone was correct 65% of the time. Symptomatic recurrence at 10 years was approximately 50% for brushite, struvite, and uric acid but approximately 30% for calcium oxalate and hydroxyapatite stones (P<.001). Recurrence was similar across different proportions of calcium oxalate and hydroxyapatite (P for trend=.10). However, among calcium oxalate stones, 10-year recurrence rate ranged from 38% for 100% calcium oxalate dihydrate to 26% for 100% calcium oxalate monohydrate (P for trend=.007). Conclusion Calcium stones are more common (93.5% of stone formers) than has been previously reported. Although clinical and laboratory factors associate with the stone composition, they are of limited utility for estimating stone composition. Rarer stone compositions are more likely to recur.
UR - http://www.scopus.com/inward/record.url?scp=84940833391&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940833391&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2015.07.016
DO - 10.1016/j.mayocp.2015.07.016
M3 - Article
C2 - 26349951
AN - SCOPUS:84940833391
SN - 0025-6196
VL - 90
SP - 1356
EP - 1365
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 10
ER -